Inclusion Criteria:

- History of early-stage breast cancer (DCIS and Stages I, II, IIIA/B, operable Stage
IIIC) as recorded in the medical record at MSKCC by self-report, or by outside
correspondence, including a study checklist signed by a physician for patients
outside of MSKCC

- >3 months from completion of treatment (may be on hormone therapy, such as tamoxifen)
as confirmed by the medical record at MSKCC, by self-report, or by outside
correspondence, including a study checklist signed by a physician for patients
outside of MSKCC

- Age 18 or older

- Access to a telephone, computer, and Internet

For Phase 2 only:

- A score of > or = to 4 on the Distress Thermometer (DT) and indication that this
distress is related in some way to the patient's breast cancer or survivorship

- If taking medication for mood, anxiety, depression, thoughts, sensory experiences
such as hallucinations, or sleep, stable and consistent in dosage and use of that
medication for at least 8 weeks, as confirmed by reports in the medical record at
MSKCC, by selfreport, or by outside correspondence, including a study checklist
signed by a physician for patients outside of MSKCC

- Did not participate in Phase 1

Exclusion Criteria:

- Evidence of other type of cancer (current diagnosis or history of
recurrence/metastasis) EXCEPT basal or squamous cell carcinoma of the skin as
confirmed by the medical record at MSKCC, by self-report, or by outside
correspondence

- Significant psychiatric or cognitive disturbance sufficient, in the investigator's
judgment, to preclude providing informed consent or participating in the groups
(i.e., acute psychiatric symptoms which require individual treatment).